chr11-2572057-G-A

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong

The NM_000218.3(KCNQ1):​c.728G>A​(p.Arg243His) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,612,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R243C) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

KCNQ1
NM_000218.3 missense

Scores

17
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7O:1

Conservation

PhyloP100: 6.15
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a helix (size 2) in uniprot entity KCNQ1_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_000218.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-2572056-C-T is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.99
PP5
Variant 11-2572057-G-A is Pathogenic according to our data. Variant chr11-2572057-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 53092.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2572057-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNQ1NM_000218.3 linkuse as main transcriptc.728G>A p.Arg243His missense_variant 5/16 ENST00000155840.12 NP_000209.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkuse as main transcriptc.728G>A p.Arg243His missense_variant 5/161 NM_000218.3 ENSP00000155840 P1P51787-1
KCNQ1ENST00000335475.6 linkuse as main transcriptc.347G>A p.Arg116His missense_variant 5/161 ENSP00000334497 P51787-2
KCNQ1ENST00000496887.7 linkuse as main transcriptc.467G>A p.Arg156His missense_variant 6/165 ENSP00000434560
KCNQ1ENST00000646564.2 linkuse as main transcriptc.478-11378G>A intron_variant ENSP00000495806

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152146
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000402
AC:
1
AN:
249024
Hom.:
0
AF XY:
0.00000740
AC XY:
1
AN XY:
135222
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000822
AC:
12
AN:
1460642
Hom.:
0
Cov.:
32
AF XY:
0.00000826
AC XY:
6
AN XY:
726644
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000630
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152146
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Jervell and Lange-Nielsen syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 18, 2019The p.Arg243His variant in KCNQ1 has been reported in 4 individuals with Jervell and Lange-Nielsen syndrome (JLNS): It was identified in the homozygous state in 3 Turkish individuals from consanguineous families (Tyson 1997, Tyson 2000, Bostan 2013, Kılıç 2014) and in the compound heterozygous state in 1 French individual (Mohammad-Panah 1999, Chouabe 2000). Relatives who were heterozygous carriers of this variant were either clinically asymptomatic for LQTS or had a modestly prolonged QT interval (Larsen 1999, Ning 2003) suggesting reduced penetrance and variable expressivity. This variant has also been reported in one individual with long QT syndrome (LQTS; Kobori 2004, Itoh 2009). In vitro functional studies support an impact on protein function (Mohammad-Panah 1999, Chouabe 2000, Huang 2001, Itoh 2009. The p.Arg243His variant has been identified in 0.004% (1/24684) of African chromosomes and 0.003% (1/30584) of South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org) and is present in ClinVar (Variation ID: 53092). Computational prediction tools and conservation analysis suggest that this variant may impact the protein. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive JLNS (ACMG/AMP Criteria applied: PM2, PM3, PP3, PS3_Supporting), but its clinical significance in LQTS is uncertain (ACMG/AMP Criteria applied: PM2, PP3, PS3_Supporting). -
Pathogenic, criteria provided, single submitterresearchDept of Medical Biology, Uskudar UniversityJan 08, 2024Criteria: PS3_Moderate, PM1, PM2, PM3_Strong, PP3 -
Jervell and Lange-Nielsen syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testing3billionJan 03, 2022The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 26022593, 23400408, PS4_S). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.954, 3CNET: 0.984, PP3_P). A missense variant is a common mechanism associated with Jervell and Lange-Nielsen syndrome (PP2_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000007, PM2_M). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000053091, PMID:10409658,16922724,19490272, PM5_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
KCNQ1-related disorder Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 19, 2023The KCNQ1 c.728G>A variant is predicted to result in the amino acid substitution p.Arg243His. This variant was reported in the homozygous or compound heterozygous state with a second pathogenic KCNQ1 variant in at least three unrelated individuals with Jervell and Lange-Nielsen syndrome (Chouabe et al. 2000. PubMed ID: 10728423; Bostan et al. 2013. PubMed ID: 23400408; Kılıç et al. 2014. PubMed ID: 26022593). Of note, heterozygous carriers have been documented with a wide range of phenotypic variability, ranging from asymptomatic, borderline QTc interval, to a clinical diagnosis of long QT syndrome (Mohammad-Panah et al. 1999. PubMed ID: 10090886; Itoh et al. 2009. PubMed ID: 19843919; Bostan et al. 2013. PubMed ID: 23400408; Table S1, Schwartz et al. 2021. PubMed ID: 34505893; Saat et al. 2022. PubMed ID: 35703482). Functional studies support the pathogenicity of this variant (Chouabe et al. 2000. PubMed ID: 10728423; Huang et al. 2001. PubMed ID: 11530100; Park et al. 2005. PubMed ID: 15746441; Coyan et al. 2014. PubMed ID: 24681627). This variant is reported in 0.0041% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-2593287-G-A). This variant is interpreted as pathogenic. -
Long QT syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 18, 2022This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 243 of the KCNQ1 protein (p.Arg243His). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg243 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10973849, 12877697, 14678125, 15234419, 15466642, 15469540, 15840476, 17470695, 19716085, 19841300, 20167303). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 10090886, 11530100, 15746441, 15935335, 19843919, 24681627). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 53092). This missense change has been observed in individuals with Jervell and Lange-Nielsen syndrome (PMID: 10728423, 23400408, 26022593). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. -
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsAug 25, 2022The p.R243H variant (also known as c.728G>A), located in coding exon 5 of the KCNQ1 gene, results from a G to A substitution at nucleotide position 728. The arginine at codon 243 is replaced by histidine, an amino acid with highly similar properties. This alteration is located in the S4 transmembrane domain and has been reported in trans with another pathogenic KCNQ1 mutation in a proband with Jervell and Lange-Nielsen syndrome (JLNS) (Chouabe C et al. Cardiovasc. Res., 2000 Mar;45:971-80). This variant has also been detected in the homozygous state in multiple Turkish probands with JLNS, while some heterozygous relatives were reported to have QTc intervals within normal limits (Huang L et al. Cardiovasc. Res., 2001 Sep;51:670-80; Bostan O et al. Pediatr Cardiol, 2013 Feb;34:2063-7; Klç E et al. Turk. J. Pediatr.;56:542-5). General population frequency data for the Turkish population is limited and the possibility that this alteration is common in the Turkish subpopulation can not be excluded. This alteration has been identified in the heterozygous state in a patient with drug-induced long QT syndrome (Kobori A et al. J. Cardiovasc. Electrophysiol., 2004 Feb;15:190-9). A number of functional studies suggest that this alteration results in deficient protein function (Mohammad-Panah R et al. Am. J. Hum. Genet., 1999 Apr;64:1015-23; Chouabe C et al. Cardiovasc. Res., 2000 Mar;45:971-80; Huang L et al. Cardiovasc. Res., 2001 Sep;51:670-80; Wilson AJ et al. Cardiovasc. Res., 2005 Aug;67:476-86; Park KH et al. Circ. Res., 2005 Apr;96:730-9; Itoh H et al. Circ Arrhythm Electrophysiol, 2009 Oct;2:511-23). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Cardiac arrhythmia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthFeb 07, 2022This missense variant is located in the fourth segment (S4) of the transmembrane domain of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have shown that this variant causes a defect in protein trafficking (PMID:15935335), reduced binding affinity for PIP2 (PMID: 15746441, 24681627), and decreased current compared to wild type (PMID: 10090886, 15746441, 19843919, 24681627). This variant has been reported in at least eight unrelated heterozygous individuals affected with long QT syndrome (PMID: 15028050, 19843919, 32893267). This variant has been also reported in homozygous or in compound heterozygous state with a known pathogenic KCNQ1 variant in four unrelated individuals affected with Jervell and Lange-Nielsen Syndrome, a severe form of long QT syndrome that also involves hearing loss (PMID: 10090886, 10728423, 23400408, 26022593, 29037160). Four heterozygous relatives from these families and another unrelated heterozygous individual (PMID:19843919) were reported to be either asymptomatic or have a modestly prolonged QT interval, suggesting reduced penetrance. This variant has been identified in 2/280356 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Arg243Cys, is known to cause long QT syndrome (Clinvar variation ID: 53091), indicating that arginine at this position is important for KCNQ1 protein function. Based on the available evidence, this variant is classified as Pathogenic. -
Congenital long QT syndrome Other:1
not provided, no classification providedliterature onlyCardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust-This variant has been reported in the following publications (PMID:9482580;PMID:10090886;PMID:11530100;PMID:15028050;PMID:18174212;PMID:19843919;PMID:10728423;PMID:11140949;PMID:15935335;PMID:10409658;PMID:15746441). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.55
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.98
.;D;.
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
D;D;D
M_CAP
Pathogenic
0.86
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.7
.;M;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.87
D
PROVEAN
Pathogenic
-4.9
D;D;D
REVEL
Pathogenic
0.95
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
1.0
.;D;D
Vest4
0.99, 0.98
MutPred
0.95
.;Loss of MoRF binding (P = 0.0315);.;
MVP
0.99
MPC
1.3
ClinPred
1.0
D
GERP RS
4.3
Varity_R
0.94
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs120074196; hg19: chr11-2593287; COSMIC: COSV50108640; API